BioPharma Resources

Investigational drug · Phase 3

OLZ

Also called: SAM, ALKS 3831

Not approved by FDA. In 2 industry-sponsored Phase 2 or 3 trials that are active or finished in the last two years, most often for Bipolar I Disorder, Schizophrenia.

Phase 3

Last checked: Nov 19, 2026Latest source record: Aug 14, 2026 (newest trial update)Source: ClinicalTrials.govMethods & limitations

Highest phase

Phase 3

Industry-sponsored trials

Phase 2 and 3 trials

2

2 still active

All registered trials

11

Any phase or sponsor naming "OLZ"

First trial start

2021

Oct 22, 2021

Sponsors

Lead sponsors of its Phase 2 and 3 trials.

All registered trials by phase

Every ClinicalTrials.gov drug study naming "OLZ", any sponsor or status.

Conditions studied

As listed on its trial records.

  • Bipolar I Disorder
  • Schizophrenia

Approved drugs for the same conditions: Schizophrenia · Bipolar disorder · Psychiatry

Largest trials

Live from ClinicalTrials.gov: studies naming "OLZ" as an intervention, largest first.

All trials

Newest research

PubMed records naming it or its code names, newest first.

All 20,671 on PubMed

Also in development for Bipolar I Disorder

  • AzetukalnerXEN1101Phase 39 trials

    Xenon Pharmaceuticals Inc. · Focal Onset Seizures, Major Depressive Disorder, Bipolar Disorder

  • NBI-1117568Phase 35 trials

    Neurocrine Biosciences · Schizophrenia, Bipolar I Disorder, Mania

  • LB-102Phase 34 trials

    LB Pharmaceuticals Inc. · Schizophrenia, Bipolar I Disorder

  • ABBV-932Phase 23 trials

    AbbVie · Bipolar I or II Disorder, Generalized Anxiety Disorder (GAD), Bipolar I Disorder

  • AL-001lithium salicylate, L-proline cocrystalPhase 23 trials

    Beijing Anlong Biopharmaceutical Co., Ltd. · Wet Age-related Macular Degeneration (wAMD), Bipolar I Disorder

  • IcalcaprantABBV-1354, CVL-354Phase 22 trials

    AbbVie · Bipolar I Disorder, Bipolar II Disorder, Major Depressive Disorder

Names are merged from how sponsors list this drug on ClinicalTrials.gov, so an alias can occasionally belong to a related compound. Development status changes faster than registry records do.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.